Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission
to discover, develop and deliver innovative medicines to patients with serious diseases.

Bristol-Myers Squibb International

Visit our global website for more information on Bristol-Myers Squibb worldwide.


March 2017 :

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer

January 2017 :

Opdivo is now reimbursed for four different types of cancer

November 2016 :

More patients with Hepatitis C will be treated in Belgium

Read more in our Press Releases in French & Dutch


pharma.be, the pharmaceutical industries’ association, celebrated its 50th anniversary by interviewing patients and professionals working in different functions in our industry; this resulted in the launch of a series of videos called #Pharmafaces.

After 5 years as a general practitioner, Dr. Paul Lacante moved to the pharmaceutical industry and is now Medical Director for Benelux at Bristol-Myers Squibb (BMS). The Medical Affairs team in a pharmaceutical firm handles many tasks including helping doctors to determine an accurate estimate of the value and best use of the medicines, with the goal of optimizing patient ca  

Dr. Paul Lacante:
“Thanks to our specialized knowledge, we can support and help the doctors. It is of the utmost importance that every patient receives the best therapy.”

Watch our

Our Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Read more about our mission

Media and Press

For any information about us, our activities and disease areas, email our Public Affairs team via pressinfo.belgium@bms.com